Home » Stocks » SENS

Senseonics Holdings, Inc. (SENS)

Stock Price: $1.58 USD 0.38 (31.67%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 388.15M
Revenue (ttm) 10.02M
Net Income (ttm) -109.15M
Shares Out 236.52M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $1.58
Previous Close $1.20
Change ($) 0.38
Change (%) 31.67%
Day's Open 1.84
Day's Range 1.50 - 2.04
Day's Volume 203,403,482
52-Week Range 0.36 - 2.04

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
InvestorPlace - 2 days ago

Senseonics Holdings (SENS) stock is on the rise Friday with heavy trading despite a lack of news concerning the pharmaceutical company. The post SENS Stock Alert: 10 Things to Know Before Inve...

Zacks Investment Research - 3 days ago

Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.

Business Wire - 1 week ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable con...

Business Wire - 3 weeks ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...

Benzinga - 3 weeks ago

This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penn...

Other stocks mentioned: BIOL, JAGX, TNXP
Zacks Investment Research - 1 month ago

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

Zacks Investment Research - 1 month ago

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Seeking Alpha - 2 months ago

Senseonics has had a large win via the Ascensia Diabetes collaboration structure, that creates shareholder value with long-tailed returns. The Eversense device will benefit from Ascensia's lar...

Seeking Alpha - 2 months ago

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Senseonics (SENS) delivered earnings and revenue surprises of -66.67% and -2.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 2 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...

Business Wire - 2 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...

Business Wire - 2 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...

Zacks Investment Research - 2 months ago

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 2 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...

Business Wire - 3 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable con...

Business Wire - 3 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...

Business Wire - 4 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

Zacks Investment Research - 4 months ago

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

Seeking Alpha - 5 months ago

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Senseonics (SENS) delivered earnings and revenue surprises of 100.00% and -76.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 5 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

Business Wire - 5 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

PRNewsWire - 5 months ago

TOKYO and BASEL, Switzerland, Aug. 10, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Ho...

Business Wire - 5 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

Business Wire - 5 months ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

PRNewsWire - 5 months ago

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciar...

Zacks Investment Research - 5 months ago

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 6 months ago

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Seeking Alpha - 7 months ago

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 7 months ago

Senseonics (SENS) delivered earnings and revenue surprises of -75.00% and -95.97%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 7 months ago

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 8 months ago

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 10 months ago

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Senseonics (SENS) delivered earnings and revenue surprises of -12.50% and 13.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

The Motley Fool - 10 months ago

An overall market sell-off stemming from increased coronavirus worries weighed on all three healthcare stocks.

Other stocks mentioned: EXAS, HQY
Zacks Investment Research - 10 months ago

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 10 months ago

The company presented data on its continuous glucose monitoring system, but investors may be more excited about being joined by George Soros.

The Motley Fool - 10 months ago

Investors reacted enthusiastically to a positive coverage decision for the company's Eversense CGM device.

The Motley Fool - 1 year ago

It wasn’t a good quarter for the diabetes-device company.

The Motley Fool - 1 year ago

The continuous glucose monitoring systems maker's main problem: declining sales.

Seeking Alpha - 1 year ago

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Senseonics (SENS) delivered earnings and revenue surprises of 0.00% and -30.14%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Iris - 1 year ago

Written by: Craig Adeyanju | FinScreener Penny stocks, on the surface, look attractive because they generally have prices under $5. However, many penny stocks belong in that category for a rea...

Other stocks mentioned: GERN, NBEV, VRAY
Seeking Alpha - 1 year ago

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Senseonics (SENS) delivered earnings and revenue surprises of -6.25% and 1.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

The Motley Fool - 1 year ago

Dilution is on the way, causing at least temporary pain for shareholders.

The Motley Fool - 1 year ago

The continuous glucose system (CGM) maker posted solid revenue growth but missed Wall Street's revenue and earnings estimates.

Seeking Alpha - 1 year ago

Senseonics Holdings Inc. (SENS) CEO Tim Goodnow on Q1 2019 Results - Earnings Call Transcript

About SENS

Senseonics Holdings, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Industry
Diagnostics & Research
Founded
1996
CEO
Timothy Goodnow
Employees
191
Stock Exchange
NYSEAMERICAN
Ticker Symbol
SENS
Full Company Profile

Financial Performance

In 2019, SENS's revenue was $21.30 million, an increase of 12.63% compared to the previous year's $18.91 million. Losses were -$115.55 million, 23.0% more than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for SENS is 0.88, which is a decrease of -44.30% from the latest price.

Price Target
$0.88
(-44.30% downside)